(Q40984061)

25 September 2017

1 reference

title

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). (English)

1 reference

25 September 2017

Morrow GR

1

1 reference

25 September 2017

Hickok JT

series ordinal

2

1 reference

25 September 2017

Rosenthal SN

series ordinal

3

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

25 September 2017

1 reference

25 September 2017

76

1 reference

25 September 2017

3

1 reference

25 September 2017

343-357

1 reference

Cardiovascular dopamine receptor stimulation antagonized by metoclopramide

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and Issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

Are granisetron and ondansetron equivalent in the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819950801%2976%3A3%3C343%3A%3AAID-CNCR2820760302%3E3.0.CO%3B2-V

10.1002/1097-0142(19950801)76:3<343::AID-CNCR2820760302>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference